Dr. Siepmann provides legal counseling services relating to the procurement of patent rights through patent prosecution and negotiation of intellectual property licensing agreements. With over twelve years of legal experience, Dr. Siepmann focuses his practice on the areas of patent preparation and prosecution, validity and infringement opinions, and intellectual property licensing. Dr. Siepmann’s technical experience includes a doctorate in biochemistry and post-doctoral studies in organic synthetic chemistry, where his studies included biochemistry techniques, organic synthetic chemistry, molecular biology, cloning, and analytical chemistry techniques. He is experienced in molecular biology technologies including therapeutic antibodies, vaccines, immunochemistry, nucleic acid sequencing, nucleic acid amplification and detection, biologics, fermentation and cell culture methods, enzymes and protein chemistry, medical devices, as well as chemical technologies including amphiphilic molecules and detergents, terpenes, nucleic acid analogs, silica-based chemistry, photochemistry, photolithography, nanoparticle technologies, process chemistry, and pharmaceutical chemistry.
Before joining BioPharma Law Group, PLLC, Dr. Siepmann was a partner at LeClairRyan, LLP. Dr. Siepmann has served as the Director, Intellectual Property for the biotechnology company Affymetrix, Inc. (acquired in 2016 by Thermo Fisher Scientific). He was also Counsel at Thompson Coburn, as well as an associate attorney at Birch, Stewart, Kolasch and Birch, LLP.
Dr. Siepmann graduated from the University of Illinois with a B.S. in Biochemistry and from the Medical College of Wisconsin with a PhD in Biochemistry. Dr. Siepmann received his J.D. degree from the University of Dayton School of Law. He is admitted to the Utah and D.C. State Bars as well as the US Patent and Trademark Office.